Incidence, temporal trends, and prognostic impact of heart failure complicating acute myocardial infarction. The SWEDEHEART Registry (Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies): a study of 199,851 patients

No abstract is available for this paper.

• Publication year

  2015

• Venue

  JACC. Heart failure

• Publication date

  2015-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jchf.2014.10.007PMID 25742760
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Better treatment and improved prognosis in elderly patients with AMI: but do registers tell the whole truth?

  2012cited by this paper
• Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction.

  2011cited by this paper
• Decreasing trends in the incidence of heart failure after acute myocardial infarction from 1993–2004: a study of 175 216 patients with a first acute myocardial infarction in Sweden

  2011cited by this paper
• Auditing patient registration in the Swedish quality register for acute coronary syndrome

  2010cited by this paper
• Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction.

  2009influential reference
• Influence of Renal Function on the Effects of Early Revascularization in Non–ST-Elevation Myocardial Infarction: Data From the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)

  2009cited by this paper
• Understanding the ‘epidemic of heart failure’: a systematic review of trends in determinants of heart failure

  2009cited by this paper
• Secular changes in cardiovascular risk factors and attack rate of myocardial infarction among men aged 50 in Gothenburg, Sweden. Accurate prediction using risk models

  2008cited by this paper
• Long-Term Trends in the Incidence of Heart Failure After Myocardial Infarction

  2008cited by this paper
• Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006.

  2007cited by this paper
• Temporal trends in the frequency and longer‐term outcome of heart failure complicating myocardial infarction

  2007influential reference
• The Cardiology Audit and Registration Data Standards (CARDS), European data standards for clinical cardiology practice.

  2005cited by this paper
• Heart failure after myocardial infarction: clinical presentation and survival

  2005cited by this paper
• Determinants and Prognostic Impact of Heart Failure Complicating Acute Coronary Syndromes: Observations From the Global Registry of Acute Coronary Events (GRACE)

  2004cited by this paper
• Incidence of heart failure after myocardial infarction: is it changing over time?

  2003cited by this paper
• The new definition of myocardial infarction: diagnostic and prognostic implications in patients with acute coronary syndromes.

  2002cited by this paper
• Early statin treatment following acute myocardial infarction and 1-year survival.

  2001cited by this paper
• Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease.

  2000cited by this paper
• Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations.

  2000cited by this paper
• Temporal trends in event rates after Q-wave myocardial infarction: the Framingham Heart Study.

  1999cited by this paper
• Twenty year trends (1975-1995) in the incidence, in-hospital and long-term death rates associated with heart failure complicating acute myocardial infarction: a community-wide perspective.

  1999cited by this paper
• Epidemiology of myocardial infarction in France: therapeutic and prognostic implications of heart failure during the acute phase.

  1999cited by this paper
• Decreasing Mortality from Acute Myocardial Infarction: Effect of Incidence and Prognosis

  1999cited by this paper
• Heart failure after myocardial infarction: the importance of diastolic dysfunction. A prospective clinical and echocardiographic study.

  1995cited by this paper
• Myocardial Infarction and Coronary Deaths in the World Health Organization MONICA Project: Registration Procedures, Event Rates, and Case‐Fatality Rates in 38 Populations From 21 Countries in Four Continents

  1994cited by this paper
• Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.

  1987cited by this paper
• Left heart failure in acute myocardial infarction. A clinical, haemodynamic and therapeutic study.

  1970cited by this paper

• Immunomodulatory effect of mesenchymal stromal cell overexpressing HLA-G1 in cell-based therapy for myocardial infarction

  2026cites this paper
• A pH/ROS dual-responsive hydrogel enabling a therapeutic trinity of anti-oxidation, anti-inflammation & anti-fibrosis for myocardial infarction repair

  2026cites this paper
• Reduced right/left ventricular blood pool T2-ratio predicts congestive heart failure after STEMI.

  2026cites this paper
• Symptom burden and secondary prevention in patients with left ventricular systolic dysfunction after acute myocardial infarction: a nationwide register-based study in Sweden

  2026cites this paper
• Prognostic usefulness of temperature in congestive heart failure with acute myocardial infarction: a retrospective cohort study

  2026cites this paper
• Prevention of Heart Failure With Icosapent Ethyl Results in Cost-Savings in the Spanish Population With Established Cardiovascular Disease.

  2025cites this paper
• Prognostic impact of cardiac dysfunctions in patients with ST-segment elevation myocardial infarction

  2025cites this paper
• Factors associated with reduced left ventricular ejection fraction in patients with primary myocardial infarction

  2025cites this paper
• Expression levels of thymosin α1 in acute myocardial infarction patients and its correlation to cardiac function

  2025cites this paper
• Role of Trimethylamine N‐Oxide in Assessing Plaque Instability of the Culprit Lesion in Chinese Patients With ST‐Elevation Myocardial Infarction: Insights From a 7‐Year Long‐Term Follow‐Up Study

  2025cites this paper
• Prevention of heart failure after acute myocardial infarction.

  2025cites this paper
• Utilizing natriuretic peptides for predicting heart failure risk following myocardial infarction

  2025cites this paper
• Early initiation of SGLT2 inhibitors in acute myocardial infarction and cardiovascular outcomes, an updated systematic review and meta-analysis

  2025cites this paper
• Development and validation of an LDH-focused nomogram for the early prediction of heart failure in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention

  2025cites this paper
• Value of peri-procedural lung ultrasound in predicting heart failure or left ventricular systolic dysfunction within 3 months in STEMI patients undergoing primary PCI

  2025cites this paper
• Impact of diabetes and ejection fraction on non-ST-Segment elevation myocardial infarction outcomes

  2025cites this paper
• Self-reported pain is associated with a poorer long-term prognosis in patients with myocardial infarction: A SWEDEHEART study

  2025cites this paper
• Integrating the Interleukins in the Biomarker Panel for the Diagnosis and Prognosis of Patients with Acute Coronary Syndromes: Unraveling a Multifaceted Conundrum

  2025cites this paper
• Clinical Predictors of Heart Failure after STEMI: Data from a Middle-Income Country with Limited Access to Percutaneous Coronary Intervention

  2025cites this paper
• Trimethylamine N-Oxide as a Biomarker for Left Ventricular Diastolic Dysfunction and Functional Remodeling After STEMI

  2025cites this paper
• Preditores Clínicos de Insuficiência Cardíaca após IAMCSST: Dados de um País de Renda Média com Acesso Limitado à Intervenção Coronária Percutânea

  2025cites this paper
• China’s fight against new-onset heart failure after acute myocardial infarction: a major stage victory

  2025cites this paper
• Reconsidering the role of beta-blockers in post-myocardial infarction patients with preserved ejection fraction.

  2025cites this paper
• Characterization of ischemic etiology in heart failure with reduced ejection fraction randomized clinical trials: A systematic review and meta-analysis.

  2025cites this paper
• Association of Serum Gamma-Glutamyltransferase with In-hospital Heart Failure in Patients with ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

  2025cites this paper
• De novo heart failure in patients hospitalized with ST-segment elevation myocardial infarction in contemporary China

  2025influential citation
• Incident heart failure and related outcomes in survivors of acute myocardial infarction within the first year in Sweden across 25 years, between 1997 and 2022

  2025cites this paper
• "Sex-Based Differences in Heart Failure Development During STEMI hospitalisation".

  2025cites this paper
• Nanoparticle-based drug delivery systems targeting inflammatory immune mechanisms in acute myocardial infarction: current advances and perspectives

  2025cites this paper
• Immediate versus delayed coronary angiography in patients with non-ST segment elevation acute coronary syndrome complicated with acute decompensated heart failure: The EARLY-HF randomized clinical trial.

  2025cites this paper
• Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial

  2024cites this paper
• Predictors of Left Ventricular Ejection Fraction Decrease in Patients With ST-Segment Elevation Myocardial Infarction.

  2024cites this paper
• Stress hyperglycaemia ratio is an independent predictor of in-hospital heart failure among patients with anterior ST-segment elevation myocardial infarction

  2024cites this paper
• Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRESS‐MI)

  2024cites this paper
• Qingre Huoxue decoction attenuates myocardial ischemia‒reperfusion injury by regulating the autophagy‒endoplasmic reticulum stress axis via FAM134B-mediated ER-phagy

  2024cites this paper
• Intestinal fatty acid binding protein is associated with infarct size and cardiac function in acute heart failure following myocardial infarction

  2024cites this paper
• Prehospital Pulse-Dose Glucocorticoid in ST-Segment Elevation Myocardial Infarction: The PULSE-MI Randomized Clinical Trial.

  2024cites this paper
• Acute-on-chronic inflammation in acute myocardial infarction

  2024cites this paper
• Predictive value of initial Lp-PLA2, NT-proBNP, and peripheral blood-related ratios for heart failure after early onset infarction in patients with acute myocardial infarction.

  2024cites this paper
• Emerging opportunities to target inflammation: myocardial infarction and type 2 diabetes

  2024cites this paper
• Long-term effects of air quality on hospital readmission for heart failure in patients with acute myocardial infarction.

  2024cites this paper
• The relative impact of components of high residual risk on the long-term prognosis after AMI

  2024influential citation
• STEMI, Revascularization, and Peak Troponin by Adverse Pregnancy Outcomes in Women With Myocardial Infarction

  2024cites this paper
• Optimizing the Effects of a Comprehensive Emergency Nursing Model on Rescued Patients with Acute Myocardial Infarction in the Cardiology Department.

  2024cites this paper
• Long-term postoperative outcomes in patients with left ventricular ejection fraction <30%

  2024cites this paper
• Prognostic Value of Integrated Assessment of Cardiac Magnetic Resonance-Derived Global Coronary Flow Reserve and Cardiopulmonary Exercise Testing-Derived Peak Oxygen Consumption in Patients With Acute Myocardial Infarction

  2024cites this paper
• Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on the Severity and the Mortality of Acute Myocardial Infarction in Japan　— Analysis From the JROAD-DPC Database —

  2024cites this paper
• Effect of SGLT-2 Inhibitors on Prognosis in Diabetic Patients with Acute Myocardial Infarction: A Systematic Review and Meta-Analysis

  2024cites this paper
• Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines

  2024cites this paper
• The Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors on Cardiovascular Outcomes and All-Cause Mortality in Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis

  2024cites this paper
• Heart Failure and Echocardiography Derived Myocardial Wall Stress Link in Diabetic Cases with Acute Myocardial Infarction Managed by Revascularization

  2024cites this paper
• Health outcomes after myocardial infarction: A population study of 56 million people in England

  2024cites this paper
• Sacubitril/valsartan improves the prognosis of acute myocardial infarction: a meta-analysis

  2024cites this paper
• Coenzyme Q10 mitigates macrophage mediated inflammation in heart following myocardial infarction via the NLRP3/IL1β pathway

  2024cites this paper
• The spectrum of post-myocardial infarction care: From acute ischemia to heart failure.

  2024cites this paper
• Prevalence and prognostic impact of left ventricular systolic dysfunction or pulmonary congestion after acute myocardial infarction

  2023cites this paper
• Modern strategy of combined antihyperlipidemic therapy in the post-infarction period: focus on phytosteroid saponins

  2023cites this paper
• Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardioprotection

  2023cites this paper
• The Effect of Family-Centered Intervention via SMS on Life Expectancy and Self-Efficacy in Medication Regimen Compliance in Patients With Acute MI: A Randomized Clinical Trial

  2023cites this paper
• Myeloid-specific knockout of SHP2 regulates PI3K/PLCγ signaling pathway to protect against early myocardial infarction injury

  2023cites this paper
• Forecasting the Risk of Heart Failure Hospitalization After Acute Coronary Syndromes: the CORALYS HF Score.

  2023cites this paper
• Heart failure at admission complicating ST-elevation myocardial infarction in a middle-income country. Experience of the ARGEN-IAM-ST Registry.

  2023cites this paper
• Reduced Left Ventricular Twist Early after Acute ST-Segment Elevation Myocardial Infarction as a Predictor of Left Ventricular Adverse Remodelling

  2023cites this paper
• Acute coronary syndrome and heart failure, another piece of the puzzle.

  2023cites this paper
• Identification of molecular signatures in acute myocardial infarction based on integrative analysis of proteomics and transcriptomics.

  2023cites this paper
• High Self‐Reported Levels of Pain 1 Year After a Myocardial Infarction Are Related to Long‐Term All‐Cause Mortality: A SWEDEHEART Study Including 18 376 Patients

  2023cites this paper
• Cardiac Troponin, Kidney Function, Heart Failure and Mortality After Myocardial Infarction in Patients With and Without Kidney Impairment.

  2023cites this paper
• Angio‐based coronary functional assessment predicts 30‐day new‐onset heart failure after acute myocardial infarction

  2023cites this paper
• Prediction of the Development of Acute Heart Failure of High Grades in Patients with Myocardial Infarction and Percutaneous Coronary Intervention

  2023cites this paper
• Declining risk of heart failure hospitalization following first acute myocardial infarction in Scotland between 1991–2016

  2023cites this paper
• Timing of heart failure development and clinical outcomes in patients with acute myocardial infarction

  2023cites this paper
• Patients With AMI and Severely Reduced LVEF, a Well-Defined, Still Extremely Vulnerable Population (Insights from AMIS Plus Registry).

  2023cites this paper
• Health care registers can be instrumental for endpoint capture in clinical diabetes trials: example of microvascular complications in Swedish patients with type 2 diabetes

  2023cites this paper
• Managing patients with sex-, race-, or ethnicity-based cardiovascular health inequities

  2023cites this paper
• Predicted clinical and economic burden associated with reduction in access to acute coronary interventional care during the COVID-19 lockdown in two European countries.

  2023cites this paper
• Mechanisms regulating vascular and lymphatic regeneration in the heart after myocardial infarction

  2023cites this paper
• Predictors of in-hospital heart failure in patients with acute anterior wall ST-segment elevation myocardial infarction.

  2023cites this paper
• Clinical Effects of Sacubitril/Valsartan Combined with Dapagliflozin in Patients with Diabetes and ST-segment Elevation Myocardial Infarction

  2023cites this paper
• Dapagliflozin reduces risk of heart failure rehospitalization in diabetic acute myocardial infarction patients: a propensity score-matched analysis

  2023cites this paper
• Increased serum albumin corrected anion gap levels are associated with increased incidence of new-onset HF and poor prognosis in patients with acute myocardial infarction.

  2023cites this paper
• The initial timing and dosage pattern of sacubitril/valsartan in patients with acute myocardial infarction undergoing percutaneous coronary intervention.

  2023cites this paper
• Prognostic Significance of New-Onset Atrial Fibrillation in Heart Failure with Preserved, Mid-Range, and Reduced Ejection Fraction Following Acute Myocardial Infarction: Data from the NOAFCAMI-SH Registry

  2022cites this paper
• Fibroblast Growth Factor 23 and Outcome Prediction in Patients with Acute Myocardial Infarction

  2022cites this paper
• Effect of scar and pacing location on repolarization in a porcine myocardial infarction model

  2022cites this paper
• ORBI SCORE VALIDATION AS PREDICTOR OF CARDIOGENIC SHOCK IN PATIENTS WITH ST ELEVATION MYOCARDIAL INFARCTION IN TWO MEDICAL CENTERS IN ARGENTINA.

  2022cites this paper
• Assessment of Ultra-Early Administration of Sacubitril Valsartan to Improve Cardiac Remodeling in Patients With Acute Myocardial Infarction Following Primary PCI: Rational and Design of a Prospective, Multicenter, Randomized Controlled Trial

  2022cites this paper
• Impact of Door-to-Balloon Time Reduction Depending on the Killip Classification in Patients with ST-Segment Elevation Myocardial Infarction Transported by Emergency Medical Services.

  2022cites this paper
• SYNTAX Score as a predictor of long-term mortality in patients with left ventricular ejection fraction less than 30% and left ventricular aneurysm Menicanti type II and III

  2022cites this paper
• Prognostic Significance of New-Onset Atrial Fibrillation in Heart Failure with Preserved, Mid-Range, and Reduced Ejection Fraction Following Acute Myocardial Infarction: Data from the NOAFCAMI-SH Registry

  2022cites this paper
• Modulation of Tissue Microenvironment Following Myocardial Infarction

  2022cites this paper
• Screening for Biomarkers Associated with Left Ventricular Function During Follow-up After Acute Coronary Syndrome

  2022cites this paper
• Preventive Effect of Bone Marrow Mononuclear Cell Transplantation on Acute Myocardial Infarction-Induced Heart Failure: A Meta-analysis of Randomized Controlled Trials

  2022cites this paper
• Spatiotemporal dynamics of macrophage heterogeneity and a potential function of Trem2hi macrophages in infarcted hearts

  2022cites this paper
• Outcomes of Elderly Patients With Acute Myocardial Infarction and Heart Failure Who Undergo Percutaneous Coronary Intervention

  2022cites this paper
• Primary Left Ventricular Unloading with Delayed Reperfusion in Patients with Anterior ST-Elevation Myocardial Infarction: Rationale and Design of the STEMI-DTU Randomized Pivotal Trial.

  2022cites this paper
• Investigating the cardioprotective effects of Fuzheng Yangxin recipe based on network pharmacology and experimental evaluation

  2022cites this paper
• IncidenCe and predictOrs of heaRt fAiLure after acute coronarY Syndrome: The CORALYS registry.

  2022cites this paper
• Precise dapagliflozin delivery by cardiac homing peptide functionalized mesoporous silica nanocarries for heart failure repair after myocardial infarction

  2022cites this paper
• Prognostic Value of Natriuretic Peptide Levels and In-Hospital Heart Failure Events in Patients With Acute Myocardial Infarction.

  2022cites this paper
• Prognostic Significance of New-Onset Atrial Fibrillation in Heart Failure with Preserved, Mid-Range, and Reduced Ejection Fraction Following Acute Myocardial Infarction: Data from the NOAFCAMI-SH Registry

  2022cites this paper